Abstract

Previously we have shown that 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), the 15-LO metabolite of arachidonic acid (AA), affects endothelial cell (EC) barrier function. In this study, we have examined the role of xanthine oxidase (XO) in 15(S)-HETE-induced EC barrier dysfunction. 15(S)-HETE induced JamA phosphorylation on tyrosine residues 164, 218 and 280 involving XO-mediated reactive oxygen species (ROS) production and Src and Pyk2 activation, resulting in its dissociation from Occludin and causing tight junction disruption with increased EC barrier permeability and enhanced leukocyte and monocyte transmigration in vitro using EC monolayer and ex vivo using arteries as models. The phosphorylation of JamA on tyrosine residues 164, 218, and 280 appear to be critical for its role in 15(S)-HETE-induced EC barrier dysfunction, as mutation of any one of these amino acid residues prevented its dissociation from Occludin and restored TJ integrity and barrier function. Feeding WT mice but not 12/15-LO-/- mice with HFD for 3 months resulted in enhanced XO expression and its activity in the artery, which was correlated with increased aortic EC TJ disruption and its barrier permeability with enhanced leukocyte adhesion. These observations provide additional support for the role of 12/15-LOX in the dysregulation of vascular permeability in response to HFD. DisclosuresNo relevant conflicts of interest to declare.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.